Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma.

Hepat Med · 2021 · PMC8572023 · PMID 34754247

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the DFS and RFS benefit in the treatment versus observation group only did not reach statistical significance, the extended survival offered to the treated patients may be relevant.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.